{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:40:49Z","timestamp":1769517649729,"version":"3.49.0"},"reference-count":92,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cardiovascular diseases (CVDs), the most common cause of mortality in rich countries, include a wide variety of pathologies of the heart muscle and vascular system that compromise the proper functioning of the heart. Most of the risk factors for cardiovascular diseases are well-known: lipid disorders, high serum LDL cholesterol, hypertension, smoking, obesity, diabetes, male sex and physical inactivity. Currently, much evidence shows that: (i) the human microbiota plays a crucial role in maintaining the organism\u2019s healthy status; and (ii) a link exists between microbiota and cardiovascular function that, if dysregulated, could potentially correlate with CVDs. This scenario led the scientific community to carefully analyze the role of the microbiota in response to drugs, considering this the right path to improve the effectiveness of disease treatment. In this review, we examine heart diseases and highlight how the microbiota actually plays a preponderant role in their development. Finally, we investigate pharmacomicrobiomics\u2014a new interesting field\u2014and the microbiota\u2019s role in modulating the response to drugs, to improve their effectiveness by making their action targeted, focusing particular attention on cardiovascular diseases and on innovative potential treatments.<\/jats:p>","DOI":"10.3390\/biomedicines9101338","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T12:29:14Z","timestamp":1632832154000},"page":"1338","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-7789","authenticated-orcid":false,"given":"Lavinia","family":"Curini","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Florence, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-9343","authenticated-orcid":false,"given":"Amedeo","family":"Amedei","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Florence, 50139 Florence, Italy"},{"name":"SOD of Interdisciplinary Internal Medicine, Azienda Ospedaliera Universitaria Careggi (AOUC), 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jamison, D.T., Breman, J.G., Measham, A.R., Alleyne, G., Claeson, M., Evans, D.B., Jha, P., Mills, A., and Musgrove, P. (2006). Cardiovascular Disease. Disease Control Priorities in Developing Countries, World Bank Publications.","DOI":"10.1596\/978-0-8213-6179-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/jech.2005.044859","article-title":"Social determinants of health: A veil that hides socioeconomic position and its relation with health","volume":"60","author":"Regidor","year":"2006","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8C","DOI":"10.1016\/S0828-282X(10)71075-8","article-title":"The impact of social determinants on cardiovascular disease","volume":"26","author":"Kreatsoulas","year":"2010","journal-title":"Can. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.21873\/invivo.11338","article-title":"Vitamin D in Cardiovascular Disease","volume":"32","author":"Nitsa","year":"2018","journal-title":"In Vivo"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-018-5653-9","article-title":"Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: Results from SAGE Wave 1","volume":"18","author":"Ruan","year":"2018","journal-title":"BMC Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.3390\/ijms16047493","article-title":"Impacts of Gut Bacteria on Human Health and Diseases","volume":"16","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Harris, E.V., De Roode, J.C., and Gerardo, N.M. (2019). Diet\u2013microbiome\u2013disease: Investigating diet\u2019s influence on infectious disease resistance through alteration of the gut microbiome. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007891"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2017.00139","article-title":"Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Papandreou, C., Mor\u00e9, M., and Bellamine, A. (2020). Trimethylamine N-Oxide in Relation to Cardiometabolic Health\u2014Cause or Effect?. Nutrients, 12.","DOI":"10.3390\/nu12051330"},{"key":"ref_12","first-page":"5","article-title":"Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-\u03baB","volume":"5","author":"Seldin","year":"2016","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ma, G., Pan, B., Chen, Y., Guo, C., Zhao, M., Zheng, L., and Chen, B. (2017). Trimethylamine N-oxide in atherogenesis: Impairing endothelial self-repair capacity and enhancing monocyte adhesion. Biosci. Rep., 37.","DOI":"10.1042\/BSR20160244"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/eurheartj\/ehz259","article-title":"Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes","volume":"40","author":"Li","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","article-title":"Gut microbiota derived metabolites in cardiovascular health and disease","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1172\/JCI72331","article-title":"The contributory role of gut microbiota in cardiovascular disease","volume":"124","author":"Tang","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","article-title":"Defining the human microbiome","volume":"70","author":"Ursell","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The Human Microbiome Project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.maturitas.2018.03.012","article-title":"Microbiota\u2013drug interactions: Impact on metabolism and efficacy of therapeutics","volume":"112","author":"Wilkinson","year":"2018","journal-title":"Maturitas"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cmet.2014.07.002","article-title":"Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology","volume":"20","author":"Patterson","year":"2014","journal-title":"Cell Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"bbaa292","DOI":"10.1093\/bib\/bbaa292","article-title":"Drug response in association with pharmacogenomics and pharmacomicrobiomics: Towards a better personalized medicine","volume":"22","author":"Hassan","year":"2020","journal-title":"Brief. Bioinform."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Benzie, I.F.F., and Wachtel-Galor, S. (2011). Cardiovascular Disease. Herbal Medicine: Biomolecular and Clinical Aspects, CRC Press.","DOI":"10.1201\/b10787"},{"key":"ref_23","unstructured":"Olvera Lopez, E., Ballard, B.D., and Jan, A. (2021). Cardiovascular Disease, StatPearls."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Interheart Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"ref_25","first-page":"25","article-title":"Obesity and cardiovascular disease","volume":"67","author":"Jokinen","year":"2015","journal-title":"Minerva Pediatrics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11892-006-0048-1","article-title":"Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome","volume":"6","author":"Duncan","year":"2006","journal-title":"Curr. Diabetes Rep."},{"key":"ref_27","first-page":"1","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","year":"2013","journal-title":"BMC Med."},{"key":"ref_28","first-page":"59","article-title":"Complexity of diabetic nephropathy pathogenesis and design of investigations","volume":"2","author":"Tavafi","year":"2013","journal-title":"J. Ren. Inj. Prev."},{"key":"ref_29","first-page":"23","article-title":"Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients","volume":"1","author":"Behradmanesh","year":"2012","journal-title":"J. Ren. Inj. Prev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fphar.2020.00685","article-title":"Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies","volume":"11","author":"Alushi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.15420\/ecr.2015.10.2.108","article-title":"Calcific Aortic Valve Disease: Molecular Mechanisms And Therapeutic Approaches","volume":"10","author":"Lerman","year":"2015","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive Oxygen Species in Inflammation and Tissue Injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sun, L., Rajamannan, N.M., and Sucosky, P. (2013). Defining the Role of Fluid Shear Stress in the Expression of Early Signaling Markers for Calcific Aortic Valve Disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084433"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.micpath.2017.01.021","article-title":"Endothelium adhesion molecules ICAM-1, ICAM-2, VCAM-1 and VLA-4 expression in leprosy","volume":"104","author":"Hirai","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_35","first-page":"573","article-title":"Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease","volume":"36","author":"Mahmut","year":"2012","journal-title":"Inflammation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific Aortic Valve Disease: Not Simply a Degenerative Process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.110.234237","article-title":"Cell\u2013Matrix Interactions in the Pathobiology of Calcific Aortic Valve Disease: Critical roles for matricellular, matricrine, and matrix mechanics cues","volume":"108","author":"Simmons","year":"2011","journal-title":"Circ. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States: 1993 to 2008","volume":"58","author":"Greenspon","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.59","article-title":"Infective endocarditis","volume":"2","author":"Holland","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1161\/01.CIR.98.25.2936","article-title":"Diagnosis and Management of Infective Endocarditis and Its Complications","volume":"98","author":"Bayer","year":"1998","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0885066614554906","article-title":"Infective Endocarditis","volume":"31","author":"Klein","year":"2014","journal-title":"J. Intensive Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_43","unstructured":"Gupta, A., and Mendez, M.D. (2021). Endocarditis, StatPearls."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.21037\/cdt.2019.10.07","article-title":"Rheumatic heart disease: Current status of diagnosis and therapy","volume":"10","author":"Peters","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10067-014-2698-8","article-title":"Acute rheumatic fever and streptococci: The quintessential pathogenic trigger of autoimmunity","volume":"33","author":"Chakravarty","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Okello, E., Kakande, B., Sebatta, E., Kayima, J., Kuteesa, M., Mutatina, B., Nyakoojo, W., Lwabi, P., Mondo, C.K., and Odoi-Adome, R. (2012). Socioeconomic and Environmental Risk Factors among Rheumatic Heart Disease Patients in Uganda. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043917"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0021-9150(98)00113-0","article-title":"Pathogenesis of atherosclerosis: A possible relation to infection","volume":"140","author":"Noll","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0300-8932(02)76673-6","article-title":"Helicobacter pylori: \u00bfun nuevo factor de riesgo cardiovascular?","volume":"55","author":"Torres","year":"2002","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2353\/ajpath.2007.051353","article-title":"Persistent Chlamydia pneumoniae Infection of Cardiomyocytes Is Correlated with Fatal Myocardial Infarction","volume":"170","author":"Spagnoli","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.15.1.1-20.2002","article-title":"Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies","volume":"15","author":"Boman","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/spid.2002.127201","article-title":"The intracellular life of chlamydiae","volume":"13","author":"Hammerschlag","year":"2002","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1073\/pnas.1111833109","article-title":"Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis","volume":"109","author":"Benagiano","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1128\/JCM.38.12.4408-4411.2000","article-title":"Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in Human Atherosclerotic Plaques by PCR","volume":"38","author":"Farsak","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_54","first-page":"40","article-title":"Pathogenesis of atherosclerosis: A multifactorial process","volume":"7","author":"Singh","year":"2002","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.23736\/S0026-4725.19.04986-7","article-title":"Helicobacter pylori and cardiovascular disease: Update 2019","volume":"67","author":"Mladenova","year":"2019","journal-title":"Minerva Cardioangiol."},{"key":"ref_56","first-page":"e394","article-title":"Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8651(03)00033-X","article-title":"Progress toward a global understanding of infective endocarditis: Lessons from the International Collaboration on Endocarditis","volume":"21","author":"Cabell","year":"2003","journal-title":"Cardiol. Clin."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus Endocarditis: A consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.spid.2006.07.001","article-title":"Group A Streptococcus","volume":"17","author":"Martin","year":"2006","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/AAC.00198-06","article-title":"Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Isolates in Portugal over an 11-Year Period","volume":"50","author":"Dias","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02072370","article-title":"Cardiovascular diseases due to viruses","volume":"1","author":"Kawana","year":"1985","journal-title":"Heart Vessels"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12985-018-0937-3","article-title":"Human cytomegalovirus infection and coronary heart disease: A systematic review","volume":"15","author":"Du","year":"2018","journal-title":"Virol. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1386-6532(99)00064-5","article-title":"The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis","volume":"16","year":"2000","journal-title":"J. Clin. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Simanek, A.M., Dowd, J.B., Pawelec, G., Melzer, D., Dutta, A., and Aiello, A.E. (2011). Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016103"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/vim.2006.19.133","article-title":"Coxsackievirus Myocarditis: Interplay between Virus and Host in the Pathogenesis of Heart Disease","volume":"19","author":"Tam","year":"2006","journal-title":"Viral Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00036-17","DOI":"10.1128\/MMBR.00036-17","article-title":"The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota","volume":"81","author":"Milani","year":"2017","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e22842","DOI":"10.1002\/jcla.22842","article-title":"Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study","volume":"33","author":"Qiu","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Amar, J., Lange, C., Payros, G., Garret, C., Chabo, C., Lantieri, O., Courtney, M., Marre, M., Charles, M.A., and Balkau, B. (2013). Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The D.E.S.I.R. Study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054461"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13238-018-0547-2","article-title":"Pharmacomicrobiomics: A novel route towards personalized medicine?","volume":"9","author":"Doestzada","year":"2018","journal-title":"Protein Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1757-4749-4-16","article-title":"Gut Pharmacomicrobiomics: The tip of an iceberg of complex interactions between drugs and gut-associated microbes","volume":"4","author":"Saad","year":"2012","journal-title":"Gut Pathog."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41584-020-0395-3","article-title":"Pharmacomicrobiomics in inflammatory arthritis: Gut microbiome as modulator of therapeutic response","volume":"16","author":"Scher","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cpt.1437","article-title":"Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?","volume":"106","author":"Sharma","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_73","first-page":"560","article-title":"Personalized medicine: Part 1: Evolution and development into theranostics","volume":"35","author":"Vogenberg","year":"2010","journal-title":"Pharm. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00498257109044386","article-title":"The Role of the Gut Flora in the Metabolism of Prontosil and Neoprontosil in the Rat","volume":"1","author":"Gingell","year":"1971","journal-title":"Xenobiotica"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ecco-jcc\/jjaa143","article-title":"Gut Microbiota-driven Drug Metabolism in Inflammatory Bowel Disease","volume":"15","author":"Crouwel","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized Nutrition by Prediction of Glycemic Responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5694\/j.1326-5377.2003.tb05445.x","article-title":"Digoxin in heart failure and cardiac arrhythmias","volume":"179","author":"Campbell","year":"2003","journal-title":"Med. J. Aust."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1235872","article-title":"Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta","volume":"341","author":"Haiser","year":"2013","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.6836275","article-title":"Digoxin-inactivating bacteria: Identification in human gut flora","volume":"220","author":"Saha","year":"1983","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2217\/fmb-2019-0338","article-title":"Eggerthella lenta bloodstream infections: Two cases and review of the literature","volume":"15","author":"Bo","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1099\/00207713-49-4-1725","article-title":"Phylogenetic evidence for the transfer of Eubacterium lentum to the genus Eggerthella as Eggerthella lenta gen. nov., comb. nov","volume":"49","author":"Kageyama","year":"1999","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/gmic.27915","article-title":"Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics","volume":"5","author":"Haiser","year":"2014","journal-title":"Gut Microbes"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_85","first-page":"4713","article-title":"Receptor crosstalk","volume":"269","author":"Dzimiri","year":"2002","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/oby.21212","article-title":"Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet","volume":"23","author":"Boutagy","year":"2015","journal-title":"Obesity"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.numecd.2019.02.003","article-title":"Differential effect of short-term popular diets on TMAO and other cardio-metabolic risk markers","volume":"29","author":"Park","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4070\/kcj.2012.42.9.583","article-title":"Personalized Medicine in Cardiovascular Diseases","volume":"42","author":"Lee","year":"2012","journal-title":"Korean Circ. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/omi.2014.0018","article-title":"Pharmacomicrobiomics: The Impact of Human Microbiome Variations on Systems Pharmacology and Personalized Therapeutics","volume":"18","author":"ElRakaiby","year":"2014","journal-title":"OMICS A J. Integr. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Amedei, A., and Boem, F. (2018). I\u2019ve Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123756"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1338\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:06:08Z","timestamp":1760166368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101338"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101338","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}